Inactive Instrument

QUANTA

Equities

QNTA

US74766N1081

Quanta Launches Proprietary Polarized CBD Product Lines

January 10, 2019

Quanta, Inc. announced that it will begin manufacturing its own line of polarized cannabidiol (CBD) products due to recent passage of the 2018 Farm Bill. The new legislature allows for relaxed federal regulation of CBD. Quanta will continue its previously agreed upon licensing arrangement with THC manufacturers.

Latest news about QUANTA

Quanta, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	23/22/23	CI
Quanta, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	16/22/16	CI
Quanta, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	23/21/23	CI
Quanta, Inc. announced that it has received $0.075 million in funding from Trillium Partners LP	12/21/12	CI
Quanta, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	24/21/24	CI
Quanta, Inc. Appoints Grant Mikaelian and Pauline Ranjbar to the Board of Directors	02/21/02	CI
Quanta, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	25/21/25	CI
Quanta, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	16/21/16	CI
Quanta, Inc. Auditor Raises 'Going Concern' Doubt	15/21/15	CI
Quanta, Inc. completed the acquisition of 51% stake in Medolife International, Inc.	14/21/14	CI
Quanta, Inc. Announces Appointment of Arthur G. Mikaelian as Chief Executive Officer	22/20/22	CI
Quanta, Inc. Announces Appointment of Arthur G. Mikaelian as Member of the Board of Directors	22/20/22	CI
Quanta, Inc. entered into a Securities Exchange Agreement to acquire 51% stake in Medolife International, Inc.	22/20/22	CI
Quanta, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	19/20/19	CI
Quanta, Inc. Announces Change of CEO	19/20/19	CI
Quanta, Inc. Appoints Phil Sands as Member of the Board of Directors	14/20/14	CI
Quanta, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	19/20/19	CI
Quanta, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	19/20/19	CI
Quanta, Inc. Begins to Ship its Quanta Branded Hand Sanitizer its Distribution Partners	29/20/29	CI
Quanta, Inc. Names Francisco Ortiz as Head of Sales	15/20/15	CI
Quanta, Inc. Announces Significant Advancements in ATP Production with Polarization Technology Platform	13/20/13	CI
Quanta, Inc. announced that it has received $0.341 million in funding	27/20/27	CI
Quanta, Inc. Announces the Addition of Eddy Pham to Advisory Board	16/20/16	CI
Quanta Announces Distribution Agreement with Hanson Faso Sales & Marketing	09/20/09	CI
Quanta, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	04/20/04	CI

Chart QUANTA

Duration

Period

More charts

Company Profile

Quanta, Inc. is an applied science company focused on increasing energy levels in plant matter to increase performance within the human body. The Company is also specialized in potentiating rare naturally occurring elements to create and sustainable solutions. The Company's technology uses quantum mechanics to increase bioactivity of targeted molecules to enhance the desired effects. The Company supports product formulations in pain management, anti-inflammation, skincare, agriculture, nutritional supplements, and plant-based consumables.

Sector

More about the company